PODD Logo

Insulet Corporation (PODD) 

NASDAQ
Market Cap
$18.44B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
295 of 774
Rank in Industry
40 of 99

Largest Insider Buys in Sector

PODD Stock Price History Chart

PODD Stock Performance

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was …

Insider Activity of Insulet Corporation

Over the last 12 months, insiders at Insulet Corporation have bought $20,600 and sold $8.88M worth of Insulet Corporation stock.

On average, over the past 5 years, insiders at Insulet Corporation have bought $1.02M and sold $24.06M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Chadwick Ana Maria (EVP, CFO & Treasurer) — $61,800.

The last purchase of 100 shares for transaction amount of $20,600 was made by Chadwick Ana Maria (EVP, CFO & Treasurer) on 2024‑08‑29.

List of Insider Buy and Sell Transactions, Insulet Corporation

2024-11-12Saledirector
508
0.0007%
$274.80$139,598-3.10%
2024-09-11Saledirector
7,628
0.0108%
$225.26$1.72M+2.30%
2024-09-10Saledirector
5,000
0.0071%
$225.84$1.13M+3.26%
2024-09-09SaleSVP & Chief Technology Officer
1,383
0.002%
$220.87$305,463+6.73%
2024-09-09SaleGroup VP, CAO and Controller
1,506
0.0022%
$221.41$333,443+6.73%
2024-08-30SaleSVP, Global Operations
1,824
0.0026%
$202.27$368,940+14.76%
2024-08-29PurchaseEVP, CFO & Treasurer
100
0.0001%
$206.00$20,600+13.40%
2024-08-28SaleSVP & Chief Technology Officer
1,387
0.002%
$203.00$281,561+13.77%
2024-06-14SaleSVP & Chief Technology Officer
1,500
0.0022%
$199.96$299,940+13.00%
2024-06-10Saledirector
7,000
0.0099%
$190.51$1.33M+12.53%
2024-06-10SaleSVP & Chief Technology Officer
2,131
0.003%
$190.43$405,806+12.53%
2024-06-04Saledirector
360
0.0005%
$182.58$65,729+16.87%
2024-05-28Saledirector
3,300
0.0048%
$180.90$596,970+15.92%
2024-02-28Saledirector
11,609
0.0166%
$162.92$1.89M+16.43%
2023-12-15Saledirector
72
0.0001%
$207.08$14,910-6.73%
2023-11-13Saledirector
35,000
0.0502%
$164.63$5.76M+16.43%
2023-09-19PurchaseSVP, Global Operations
1
<0.0001%
$168.92$169+10.05%
2023-08-28PurchasePresident and CEO
5,550
0.008%
$181.41$1.01M+0.03%
2023-07-03SaleEVP, CFO
1,388
0.002%
$282.94$392,721-35.02%
2023-06-20SaleSVP, Chief HR Officer
175
0.0003%
$290.00$50,750-35.79%

Insider Historical Profitability

29.36%
Scannell Timothy Jdirector
30586
0.0436%
$262.8713+15.22%
Hopfield Jessicadirector
26917
0.0384%
$262.8721+45.84%
Chadwick Ana MariaEVP, CFO & Treasurer
13314
0.019%
$262.8710
Singh PremSVP, Global Operations
3656
0.0052%
$262.8711
SULLIVAN PATRICK JCEO and Chairman of the Board
261544
0.3729%
$262.8760+25.47%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$1.41B11.718.2M+2.11%+$29.05M0.03
Capital Research Global Investors$1.3B10.87.56M-20.2%-$328.15M0.29
BlackRock$1.03B8.66.03M-1.26%-$13.16M0.02
Fidelity Investments$926.06M7.715.4M-8.02%-$80.73M0.06
State Street$500.35M4.172.92M+1.19%+$5.87M0.02
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.